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Abstract
Otitis media is a middle ear disease common in children under three years old. Otitis media can occur in normal individuals
with no other symptoms or syndromes, but it is often seen in individuals clinically diagnosed with genetic diseases such as
CHARGE syndrome, a complex genetic disease caused by mutation in the Chd7 gene and characterized by multiple birth
defects. Although otitis media is common in human CHARGE syndrome patients, it has not been reported in mouse models
of CHARGE syndrome. In this study, we report a mouse model with a spontaneous deletion mutation in the Chd7 gene and
with chronic otitis media of early onset age accompanied by hearing loss. These mice also exhibit morphological alteration
in the Eustachian tubes, dysregulation of epithelial proliferation, and decreased density of middle ear cilia. Gene expression
profiling revealed up-regulation of Muc5ac, Muc5b and Tgf-b1 transcripts, the products of which are involved in mucin
production and TGF pathway regulation. This is the first mouse model of CHARGE syndrome reported to show otitis media
with effusion and it will be valuable for studying the etiology of otitis media and other symptoms in CHARGE syndrome.
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Introduction
Otitis media (OM), inflammation of the middle ear, is the most
prevalent disease in children [1]. OM leads to 24 million pediatric
office visits and $4 billion in health care costs annually in the
United States [2]. The pathogenesis of otitis media is influenced by
multiple factors such as exposure to infectious pathogens,
Eustachian tube anatomy, immunologic status, genetic predispo-
sition, and innate mucosal defense [3]. The observations of a
higher incidence of OM in white infants than in black and Asian
infants and of the high incidence of OM in patients with genetic
disease, such as CHARGE syndrome studied in this paper,
indicate that genetic factors play an important role in development
of otitis media [4].
CHARGE syndrome, a multiple congenital anomaly syndrome,
has an incidence of approximately 1 in 10,000 individuals globally
[5]. CHARGE syndrome is characterized by retarded growth and
development as well as abnormalities of the eye, heart, choana,
genitalia, and middle and inner ear. [6]. Virtually all individuals
with CHARGE syndrome have recurrent otitis media with
effusion in their first year of life. Approximately two-thirds of
individuals clinically diagnosed with CHARGE syndrome have a
mutation in the Chd7 gene [7], encoding the chromodomain
helicase DNA-binding protein 7 (CHD7). Recent evidence
suggests that Chd7 functions as a regulator of genes which play a
role in cell-lineage specification in the nucleus and as a positive
regulator of rRNA biogenesis in the nucleolus [8,9,10].
Here we present a novel mouse model for CHARGE syndrome
with a spontaneous deletion mutation in the Chd7 gene. This
mouse model exhibits a high incidence of otitis media and
associated hearing loss together with several other features that are
commonly observed in CHARGE patients such as eye abnormal-
ity, growth retardation, and balance defects. Otitis media was not
reported in any of the previously described animal models for
CHARGE syndrome and to date, there are no published studies
that have examined the pathogenesis of otitis media in human
CHARGE syndrome patients [11]. By further study, we found
that Eustachian tube dysfunction, dysregulated epithelial prolifer-
ation, and decreased middle ear cilia density can explain the
incidence of OM in Chd7 mutant mice. This mouse model
facilitates the study of serous otitis media etiology in CHARGE
syndrome patients and helps establish a common pathway for
development of otitis media in humans in general.
Results
Circling mice have a deletion mutation in the Chd7 gene
We identified a spontaneous mouse mutant exhibiting head
bobbing and circling behavior transmitted in an autosomal
dominant fashion. To determine the chromosomal location of
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34944the Ome mutation, heterozygous Ome mice on the BALB/cByJ
background were mated with inbred C57BL/6J mice to generate
F1 mice. Those F1 mice that exhibited circling behavior were
backcrossed to BALB/cByJ inbred mice to produce N2 mice.
Ninety of 180 total N2 progeny were affected. From these 90,
genomic DNA was prepared as previously described [12] and
genotyped by polymorphic microsatellite marker analysis via
agarose electrophoresis, utilizing standard conditions and proto-
cols. The initial genome scan was carried out on pooled DNA
samples. After detection of linkage on Chr 4, microsatellite
markers D4Mit149, D4Mit235, D4Mit181, D4Mit18, D4Mit1,
D4Mit292, and D4Mit193 were scored on individual DNA
samples. Candidate genes localized to the critical region between
markers D4Mit181 (4.23 cM, NCBI Build 37, 9501070–9501202)
and D4Mit18 (6.01 cM, NCBI Build 37, 13937604–13937829)
were identified by scanning the Ensembl genome database
(Release 62).
Based on these mapping studies, and given that these mice show
a remarkably similar phenotype to other mouse models with
known mutations in Chd7, we hypothesized that these mice
harbored a mutation in the Chd7 gene, and set out to identify the
causative mutation. Because most reported Chd7 mutations are of
the nonsense and frameshift type, we first sequenced the mouse
Chd7 gene by conventional Sanger sequencing to identify such a
mutation. Several DNA variants were detected between Ome and
mouse sequence NCBIM37; however, all were predicted to be
benign polymorphisms (data not shown) and no difference
between Ome/+ and littermate +/+. We then tested whether the
mice harbored a heterozygous deletion or duplication mutation
within the Chd7 gene, which would have evaded detection by
conventional DNA sequencing. To do this, we quantified Chd7
exon copy number by quantitative PCR (qPCR) of genomic DNA
isolated from mutant and wild-type mice. Relatively similar levels
of Chd7 exons 1, 4, 6, 18, and 38 were detected between wild-type
and mutant mice (Figure 1A). However, Chd7 exons 2 and 3 were
amplified to levels approximately one-half of those in wild-type
mice, consistent with a heterozygous deletion of these two exons.
Genomic deletion of Chd7 exons 2 and 3 resulted in an mRNA
transcript with exon 1 aberrantly spliced to exon 4 (Figure 1B, C).
The translation initiation codon is located in exon 2, and in silico
translation of the aberrant Chd7 transcript predicts a protein
containing a premature stop codon. We therefore conclude that
the deletion of Chd7 exons 2–3 is the causative mutation in these
mice, likely resulting in haploinsufficiency of Chd7.
Ocular anomalies, growth retardation, and circling
behavior in mutant mice
Keratoconjunctivitis sicca was observed in about 60% of the
mutant mice (Table 1). Though mutant mice have smaller body
size and weight at weaning age (Table 1), their life span is
comparable to that of wild-type mice. Mutant breeder males can
live at least 12 months until retired from breeding (data not
shown). Chd7
Ome/+ male mice were slightly less fecund than wild
type, but most breeding pairs succeeded to generate offspring.
Chd7
Ome/+ mice also showed circling behavior (Video S1) and poor
swimming ability (Video S2), which directly indicates a balance
defect, compared to a normal swimmer (Video S3).
Hearing deficiency was detected in Chd7 mutant mice
A time-course observation of the ABR thresholds of Chd7
Ome/+
and wild-type mice is shown in Figure 2. The results showed that
the mean ABR thresholds of Chd7
Ome/+ mice in each age-group
from P21 to P120 (n$3 at each time point) were significantly
higher than those of wild-type mice at all the frequencies tested
(Figure 2A). We also performed DPOAE tests over a similar time
course and the results showed that mutant mice have amplitudes
below zero at every frequency tested from P21 to P120 (n$3a t
each time point), substantially lower than those in wild-type mice
(Figure 2B). Tympanometry measurement showed lower compli-
ance values in the mutant mice (Figure 2C), which indicate
abnormal middle ear function in the mutant mice. Though the
mutant mice with otitis media tended to show cochlear
microphonics (CM) responses at higher sound pressure levels
compared to responses at lower sound pressure levels in littermate
control mice, all the mutant mice (n=5) did successfully generate
CM peaks (Figure 2D).
Otitis media was observed in a majority of Chd7
Ome/+
mice
To evaluate the incidence rate of otitis media in Chd7
Ome/+ mice,
12 mice ranging in age from 21 to 77 days were randomly selected
for otitis media screening by otoscopic and histological analysis. Of
the 12 Chd7
Ome/+ mice examined, all 12 had effusion in the middle
ear space of one or both ears, although the effusion volume varied
(Table 2). Figure 3 shows representative images of the histology of
Chd7
Ome/+ mouse ears. Effusion (Figure 3B, E, K), thickened
epithelia (Figure 3E, K), a dilated periosteum (Figure 3K), and
inflammatory cells (Figure 3L, M) were observed in most of the
mutant mice. Effusion with inflammatory cells was also observed
in the Eustachian tube opening in the middle ear cavity of most of
the mutant mice (Figure 3I). The effusion content was quite
variable with respect to quantity of inflammatory cells, which
consisted mainly of polymorphonuclear cells (Figure 3L, M).
Additionally, in Chd7
Ome/+ mice, goblet cells were found at higher
density among other cells in the epithelium of the middle ear
cavity (Figure 4B) and in the Eustachian tube duct (Figure 4D). By
contrast, control mice exhibited few goblet cells in comparable
sections of the mucosae of the middle ear cavity and Eustachian
tube (Figure 4A and C). Hair cells and spiral ganglion cells were
normal in both mutant and wild-type mice (Figure 3F, G). We also
observed abnormal stapes in the mutant mice (Figure 3C). The
head of the stapes in the mutant mouse was shifted toward the
anterior crus and the obturator foramen was smaller because of
inward growth of the footplate and anterior crus; the footplate was
thinner and partially fused with surrounding bones. In studying
the middle ear histology of P11 and P15 mice, we found that the
onset of otitis media in the Chd7 mutant mice can be as early as
11 days old (data not shown).
No bacteria known to cause otitis media detected in the
mutant or wild-type mice
ToassesswhethertheotitismediawitheffusioninChd7
Ome/+mice
is caused by bacteria, we applied PCR identification [13] and
bacterial culture techniques to detect pathogens in the Chd7
Ome/+
mice and wild-type mice. Three specific primer pairs for the three
most common otitis media-associated pathogens were used in a
diagnostic PCR reaction [13]. None of the three pathogens
(Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and
Moraxella catarrhalis) were detected (n=4 for each group) by
diagnostic PCR. Nor were the three pathogens detected in cultures,
but comparable levels of Streptococci were identified in both mutant
and wild-type mice (four mice of each genotype were analyzed).
Decreased epithelial cilia density and increased goblet
cell density in middle ears of mutant mice
In the middle ear cavity, the Eustachian tube, and other organs
including the lung, cilia function in clearance of normal secretions
Chd7 Deficiency Correlates with Otitis Media
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have increased incidence of otitis media [15]. Using scanning
electron microscopy, we assessed the integrity of the mucociliary
epithelium in 1-month-old and 12-month-old wild-type and
Chd7
Ome/+ mice (n=3 each genotype). At 1 month, the cilia in
mutant mice were indistinguishable in number and morphology
from those in wild-type mice, indicating that Chd7 mutation had
no effect on development of the middle ear cilia. However,
increased goblet cells and swollen epithelia were observed in the
mutant mice despite normal ciliary morphology (Figure 4B,
Figure 5B). In 12-month-old mutant mice, rarefied and shortened
cilia and a high density of goblet cells were observed in the
epithelia (Figure 5D). These results indicate that progressive loss of
cilia is associated with otitis media.
Skull measurement reveals abnormalities in mutant mice
Craniofacial abnormalities are observed in CHARGE syn-
drome patients and are often related to increased OM incidence;
thus, skull measurements were performed on age-matched mutant
and control mice to detect whether mutant mice differ in skull
Figure 1. Identification of a heterozygous Chd7 deletion mutation (Chd7
Ome/+) in circling mice. (A) Quantitative PCR analysis of Chd7 exons
1, 2, 3, 4, 6, 18, and 38 on chromosome 4 using genomic DNA isolated from wild-type (WT1 and WT2) and heterozygous mutant mice (HET1 and
HET2). Genomic regions corresponding to the Spag9 (on Chr 11) gene and the Rlbp1l1 gene (also known as Clvs1; located on Chr 4, downstream of
Chd7) were also amplified and serve as additional controls. Data were normalized to Spag9 and the band for this gene was assigned the value of 1.0 (y
axis). (B) qPCR analysis of cDNA generated from wild-type and Chd7 mutant mouse brain RNA. PCR primers anchored in exons 1 and 4 (1F/4R) yield a
positive result only for cDNA from heterozygous mutant mice. This product fails to amplify from wild-type cDNA because of its large size (,2 kb). As
expected for a heterozygous deletion mutation, PCR primers anchored in Chd7 exons 1 and 2 (1F/2R) yield amplicons from both wild-type and
mutant samples. ‘‘Neg’’ indicates a non-template control sample. A 100-bp standard was run in the lane near the right edge of the gel. Asterisks
indicate bands that were isolated for sequencing in C. (C) Partial cDNA sequence of the bands isolated in panel B verifies that the mRNA transcribed
from the mutant allele results from aberrant splicing of exons 1 and 4. The translation initiation codon is indicated in exon 2 of the wild-type allele,
and has been deleted from the mutant allele.
doi:10.1371/journal.pone.0034944.g001
Table 1. Phenotype penetration in Chd7
Ome/+ mice.
Phenotype Indicator Mutant mice Wild-type mice
Keratoconjunctivitis sicca Gross examination 9/15 (60%) 2/16 (12.5%)
Mild growth retardation Body mass at age P21 (mean) 10.362.7g* 12.462.0g
Hearing impairment ABR threshold 10/10 (100%) 1/10 (10%)
Circling/ head bobbing Gross examination 10/10 (100%) 0/10 (0%)
doi:10.1371/journal.pone.0034944.t001
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larger nose bone length/skull length ratio and a greater
Eustachian tube angle when compared to littermate control mice
(Figure 6), indicating craniofacial abnormalities in Chd7 mutant
mice.
Chd7 postnatal expression and cytokine expression in the
middle ear
Studies have shown that Chd7 is widely expressed during murine
and human embryonic development [16,17]. Recently, Chd7 was
found to be expressed in the developing human and mouse




Ome/+ mice ranging in age from P21 to P120 (n=13, 13, 7 and 3, respectively, in each age-group) and Chd7
+/+ littermate mice
(n=11, 17, 17 and 4, respectively, in each age-group) were assessed for ABR thresholds at click, 8 kHz, 16 kHz and 32 kHz. Mean ABR thresholds in
Chd7
Ome/+ mice were about 20 dB SPL higher than mean thresholds of Chd7
+/+ littermate mice for all the frequencies tested, with significance
indicated by asterisks (**P,0.01). (B) DPOAE amplitudes in a different set of mutant and wild-type mice at P21 (n=4), P60 (n=6) and P120 (n=6).
DPOAE amplitudes of mutant mice were undetectable at all three ages while control mice had normal DPOAE amplitudes. Error bars indicate
standard deviation from the mean at each time point, for each mouse group. (C) Comparison of the values of tympanometry parameters in the right
ears of Chd7
Ome/+ mice (n=3) and littermate control mice (n=4) at P90. Mean ear volume and compliance values in the mutant mice were
significantly lower than those of littermate control mice (*, P,0.0001; **, P,0.05). (D) Both wild-type (WT) and Chd7
Ome/+ mice had normal CM
recording, indicating normal inner ear function in the Chd7 mutant mice even though DPOAE amplitudes were absent (data not shown). CM peaks
from left ears of one mutant Chd7
Ome/+ mouse and one littermate control at 70 dB SPL are displayed.
doi:10.1371/journal.pone.0034944.g002
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Chd7 is expressed during development of the middle ear cavity and
whether this expression may be related to the incidence of otitis
media, postnatal wild-type mouse tissues were stained with anti-
Chd7 antibody. Immunohistochemical staining revealed expression
of the Chd7 protein in the middle ear epithelia and in the inner ear
organ of Corti, limbus, and spiral ganglion cells (Figure 7A–E). We
also investigated the expression levels of Muc5a, Muc5b, Tgf-b1 and
Tlr2 genes which have been reported to be involved in the
development of otitis media and inflammation. Total RNA was
generated from middle ear tissue of equal mass from mutant and
wild-type littermate control mice (all were 2 months old). cDNA
was synthesized by reverse transcription for semi-quantitative RT-
PCR to profile the gene expression levels. Our study showed
elevated expression levels of Muc5a, Muc5b and Tgf-b1 in the
mutant middle ears compared to that in wild-type samples
(Figure 8). Chd7 (detected with primers Chd7F and Chd7R) and
Tlr2 (detected with primers Tlr2F and Tlr2R) genes were expressed
in mouse ears, but transcription levels varied both in mutants and
in wild-type littermate controls and did not show significant
differences between the two genotypes (N=8, data not shown).
Discussion
Here we report the first spontaneous deletion mutation in the
Chd7 gene in mice. The phenotype and dominant inheritance of
Ome mice are similar to those of mice with ENU mutagenesis-
induced point mutations in the Chd7 gene [19], including dizzy
(Dz), eddy (Edy), and cyclone (Cy), and the unproven alleles wheels
(Whl) and wheels-like (Whll). We report hearing loss in the Chd7
Ome
mutant mice and we provide evidence that otitis media is the
major cause of hearing loss in this mouse model. The Chd7
Ome/+
mice also presented ocular abnormalities, balance defects, and
growth retardation, all of which are consistent with the symptoms
of human CHARGE syndrome patients and previously reported
animal models for CHARGE syndrome [18,19,20,21,22,23].
Hearing loss was observed in the Chd7
Ome/+ mutant mice
starting from the age of weaning, and this loss was relatively stable
over time. At younger ages (1–2 months old), the inner ears of the
Chd7 mutant mice appeared normal compared to littermate
controls. There was very little hair cell loss; the density of spiral
ganglion cells was comparable to that in the control mice, and no
stereocilia loss was evident at this stage. However, in the middle
ear, both effusion and thickened epithelia were observed in most of
Table 2. Semi-quantitative evaluation of middle ear inflammation in Chd7
Ome/+ mice
Mouse ID Age Effusion Inflammatory cells Tissue debris Tissue proliferation
Wild type 1 22d – – – –
2 27d – – – +
3 29d – – – –
4 31d – – – –
5 31d – – – –
6 35d – – – +
7 35d + + – +
8 35d + –– +
9 35d + + + +
10 35d – – – –
11 37d – – – –
12 77d – – – –
13 77d – – – –
14 77d – – – –
15 77d – – – –
16 77d + –– –
Mutant 1 21d +++ ++ ++ ++
2 22d +++ + + +++
3 22d ++ + + +++
4 22d + + + ++
5 22d +++ ++ ++ +++
6 27d +++ ++ ++ +++
7 33d + + + +++
8 37d + + + +++
9 37d + + + +++
10 41d +++ ++ + ++
11 61d +++ ++ + +++
12 77d ++ ++ – ++
Mice from 21 to 77 days of age were used because of the early onset of otitis media in the mutant mice. Scoring system is described in the methods section. The total
scored rate (85/144) of the four indicators in Chd7
Ome/+ mice was significantly higher than that (12/240) of the wild-type mice (P,0.01, chi-square test).
doi:10.1371/journal.pone.0034944.t002
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dominant at this stage, which was also confirmed by the absence
of DPOAE amplitudes in mutant mice. At an older age (7 months
old), mutant mice observed by SEM exhibited hair-cell bundle loss
from the cochlear basal turn, and this loss may have been caused
by middle ear infection. At this stage, otitis media with effusion
was predominant in the mutant mice; thus, mixed hearing loss
caused by a combination of otitis media and stereocilia loss was
dominant, in contrast to the earlier time point. Combining the
results of histological and electrophysiological study, we conclude
that hearing loss in the Chd7 mutant mice is primarily caused by
otitis media.
Otitis media is a multifactorial disease in which pathogenesis is
affected by Eustachian tube structure and function, host immune
status, innate mucosal defense, pathogen virulence, and strain and
genetic susceptibility loci [3,24]. Any genetic deficiency that
influences one or more of these factors can promote susceptibility
to otitis media. Tlr2
-/- mice are more vulnerable to the challenge
of gram-positive bacterium S. pneumoniae because of impaired
bacterial clearance ability that leads to acute otitis media in this
model [25]. Eya4-deficiency leads to Eustachian tube dysfunction
and renders the mice susceptible to otitis media [2]. C3H/HeJ
mice with a missense mutation in the Tlr4 gene have a retarded
response to endotoxin and an increased susceptibility to otitis
media [26]. Evi1-null mice exhibited increased susceptibility to
otitis media, caused by impaired transcriptional regulation of
mucin genes in neutrophils through a TGF-b/SMAD signaling
pathway [1]. Mutations in the Fbxo11 gene discovered in Jeff mice
lead to impaired regulation of TGF-b signaling and associated
craniofacial abnormalities and thus cause impaired inflammatory
responses in the middle ear [27,28,29]. In our study of Chd7-
deficient mice, we found that abnormal Eustachian tube structure
and function, dysregulated epithelial proliferation and decreased
Figure 3. Middle ear and inner ear histology in Chd7
Ome/+ mice. (A–B) Effusion (blue arrows) and tympanic membrane retraction (blue
asterisk) can be seen in the mutant mice. (C) In the mutant mice, the head of the stapes is moved toward the anterior crus (white arrow); the
obturator foramen is smaller because of inward growth of the footplate and anterior crus (white arrowheads); the footplate is thinner and partially
fused with surrounding bones (red asterisk). (D–E) In mutant mice, effusion was evident with a small amount of inflammatory cells (yellow asterisk);
the tympanic membrane (yellow arrow), middle ear epithelia (upper right yellow arrowhead) and round window ridge (central yellow arrowhead)
were thickened. (F–G) Enlarged images from corresponding control and mutant mice (white rectangles in D and E) to show the inner ear
morphology; SV, stria vascularis; RM, Reissner’s membrane; TM, tectorial membrane; IHC, inner hair cell; OHC, outer hair cell; SPG, spiral ganglion
neuron. (H–I) Eustachian tube openings in the control and mutant mice. MEC, middle ear cavity. (J–K) Dilated periostea (green asterisk) and
thickened epithelia (white arrows) were observed in the mutant mice. (L–M) Inflammatory cells in the MEC of mutant mice. (N–O) Eustachian tube
openings in six-month-old mutant mice and littermate control mice. Scale bars: D, E, F, G, I=100 mm; H, J, K, L, M=50 mm.
doi:10.1371/journal.pone.0034944.g003
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media with effusion.
The Eustachian tube performs critical functions affecting the
middle ear in regulation of pressure, protection from nasopha-
ryngeal secretions and other foreign material, and clearance of
middle ear secretions [30]. Craniofacial abnormalities are often
related to structural and functional changes in the Eustachian
tube, thus increasing susceptibility to otitis media [29]. Our study
shows that when compared to wild-type control mice, Chd7 mutant
mice have abnormal skulls and Eustachian tubes of altered shape
and larger tube angle, indicating possible Eustachian tube
dysfunction. Further histological analysis of the middle ear cavity
from mutant mice revealed a narrow Eustachian tube lumen
caused by epithelial proliferation and a high density of goblet cells
which together lead to increased mucus. These features are
evidence of impaired structure and function of the Eustachian tube
in mutant mice, and such changes would mechanically impede
clearance of secretions in the middle ear cavity, therefore
rendering the mice more susceptible to recurrent otitis media.
In addition to impaired Eustachian tube function, mucosal
hyperplasia is a major feature of otitis media, contributing to
symptoms and causing irreversible middle ear disease [31]. Middle
ears of the mutant and wild-type mice examined by H&E staining
indicated that 100% of the mutant mice had moderate to severe
epithelial hyperplasia with or without effusion from as early as P11,
while middle ear cavities (MECs) of wild-type mice were clear and
showed no abnormalities of MEC epithelial layers. Immunohisto-
chemical staining of middle ears from young postnatal mice
indicated postnatal Chd7 expression in the MEC epithelia during
middle ear cavitation. Early onset of otitis media confirmed that
middle ear epithelia dysmorphology corresponded to developmen-
tal expression of Chd7. In the mucociliary (respiratory) type of
epithelium of the middle ear cavity, there are numerous mucin-
secretingcells[32].Mucinssecretedbythesecellsplayanimportant
role in several processes that are crucial for the protection and
function of the underlying epithelium. These processes include
mechanical protection of the epithelium, mucociliary clearance of
pathogens and particulate matter, antigen presentation, and
prevention of pathogen adherence and host invasion [32]. These
mucins interact with pathogens and protect the underlying
epithelium from invasion and mechanical damage.
Effusion was seen in most Chd7
Ome/+ ears but the amount and
composition of the effusions varied with age. At early ages, most
effusion was aqueous with very few inflammatory cells. Excessive
effusion, even without inflammatory cells, can impede mucociliary
clearance leading to mucostasis and associated hearing loss.
Especially when epithelial proliferation is severe, impaired
epithelial function and consequent diminished ciliary density
make this process irreversible, thus causing chronic otitis media
with effusion.
Immunodeficiency has been reported in CHARGE syndrome
patients and is characterized by hypogammaglobulinemia, IgG2
subclass deficiency, impaired specific antibody responses, and T-B
cell and/or natural killer cell defects [33,34,35,36]. Bacterial
culture indicated comparable bacteria levels in Chd7 mutant mice
and wild-type mice. Impaired immunity in the mutant mice could
Figure 4. Representative sections of the middle ear and Eustachian tube mucosae of Chd7
+/+ and Chd7
Ome/+ littermates. Few goblet
cells could be found in the middle ear (A) and Eustachian tube mucosae (C)o fChd7
+/+ littermate mice. By contrast, goblet cells were present at high
density among other cells in the epithelium of the middle ear cavity (B) and the duct of the Eustachian tube (D)o fChd7
Ome/+ mice (typical goblet
cells are indicated by arrows). Goblet cells have a distinctly polarized morphology in which the nucleus stains black in color at the cell base, and the
mucus stains a deep rose color in the middle and apical portions of the cell. Scale bars =50 mm.
doi:10.1371/journal.pone.0034944.g004
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presence of bacteria flora.
In previously reported mouse models for otitis media, expression
of the mucin gene family [37,38] and the TGF signaling pathway
[27] were affected. In this study, we profiled the expression levels
of Muc5ac and Muc5b and Tgf-b1 genes. Mucins are heavily
glycosylated proteins that are considered primarily responsible for
the gel-like characteristics of mucoid middle ear fluids. To date, 18
human mucin genes coding for mucin glycoproteins have been
identified [39]. MUC5AC, MUC5B, and MUC2 are the key
molecules that determine the properties of airway mucus gel [40].
These proteins participate in protecting the underlying middle ear
epithelium from pathogen invasion and pathogen damage and
assist with pathogen clearance. However, overproduction of these
mucins can lead to increased viscosity of middle ear fluids, limited
mucociliary clearance, and eventual mucin accumulation in the
middle ear, ultimately leading to hearing loss. TGF-b1i sa n
important immunoregulatory mediator and participates in the
middle ear inflammatory response and in other processes including
apoptosis and tissue proliferation. Our discovery that mucin genes
and TGF-b1 in the middle ear are upregulated is consistent with
findings in human chronic otitis media patients [37,38,41]. These
findings further support the Chd7
Ome/+ mutant mice as an ideal
model to study the genetic pathways involved in human chronic
otitis media. Tlr2 gene expression was not significantly different
between Chd7
Ome/+ mutant and control mice, suggesting that Tlr2
is less involved in this chronic OM process. This result is consistent
with the fact that no pathogenic bacteria were identified in this
mutant though comparable levels of Streptococci were identified in
both mutant and wild-type mice. In contrast, the TLR2-mediated
immune response is significantly involved in S. pneumoniae-induced
acute otitis media [25]. Chd7 was expressed in mouse ears, which
suggests that Chd7 plays a direct role in ear development and ear
disease processes including OM. Chd7 transcript levels were not
found to be significantly different between wildtype and Chd7
Ome/+
mutant mice, suggesting that the presence of the deletion mutation
does not necessarily lead to non-sense mediated mRNA decay.
However, due to a premature stop codon in the mutant transcript,
the CHD7 protein level in heterozygous mice is predicted to be
half that of the +/+ mice, and this haploinsufficiency of Chd7
would lead to otitis media and other phenotypes.
Chd7
Ome/+ mice are a valuable model for human CHARGE
syndrome because of a series of phenotypes that mimic human
symptoms, including growth retardation, balance defects, otitis
media, and hearing loss. Otitis media in Chd7
Ome/+ mice is
characterized by Eustachian tube dysfunction, epithelial hyperpla-
sia, middle ear effusion and associated hearing loss. All of these
typical otitis media features make Chd7
Ome/+ mice a useful model for
human otitis media. Further study of Chd7-associated genes that
influence morphology and physiology of middle ear epithelia and
the Eustachian tube may indicate new pathways with therapeutic
potential for CHARGE syndrome and human otitis media.
Figure 5. Scanning electron micrographs of middle ear cavities of Chd7
Ome/+ mice and littermate control mice. (A, B) Lateral views of
Eustachian tube ostium epithelia in 1-month-old wild-type (A) and Chd7
Ome/+ (B) mice show increased goblet cells in Chd7
Ome/+ mice while ciliary
morphology is indistinguishable from that in wild-type mice. Red asterisk identifies one of many goblet cells. (C, D) Rarefied cilia (green arrowhead)
and scattered goblet cells (red asterisk) were observed in the mucociliary epithelia at the Eustachian tube ostia of 12-month-old Chd7
Ome/+ mice (D),
while the cilia in age-matched wild-type mice (C) appeared normal. Scale bars =15 mm.
doi:10.1371/journal.pone.0034944.g005
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Mice
Mice exhibiting head bobbling/circling behavior and with otitis
media and eye defects (Ome mice) were first observed in at The
Jackson Laboratory (JAX, Bar Harbor, Maine), then imported to
Case Western Reserve University. Mating of an affected Chd7
Ome/+
male to a BALB/cByJ female revealed an autosomal dominant
mode of inheritance. The mutant from a BALB/cByJ X CAST/Ei
hybrid was backrossed 10 times to the BALB/cByJ background.
Because circling females were not good breeders, mating pairs
were usually arranged with a heterozygous male and a wild-type
female. Mice were housed in ventilated racks at 21uC in a 12 h
light–dark cycle with food and water given ad libitum. All animal
protocols (R01DC009246, R01DC007392 and R21DC005846)
were approved by the Institutional Animal Care and Use
Committee of Case Western Reserve University.
Sequencing and Genotyping
We sequenced genomic DNA, amplifying each exon of all the 40
exons of the Chd7 gene (or two exons when they were near each
other) separately by standard PCR, then performed Sanger
sequencing using BigDye Terminator v3.1 Cycle Sequencing
chemistry (ABI) and gave the reactions to the sequencing core for
electrophoresis on an ABI 3730 DNA Analyzer. Primer pairs (data
not shown) flanking each exon are designed according mouse
genomic sequence (NCBIM37) Chromosome 4: 8,617,553–
8,794,806 forward strand (Chd7 ENSMUSG00000041235). No
DNA sequence difference was detected between Ome/+ and +/+
mice. Then, we performed the real-time PCRs with genomic and
cDNA (using SYBR green PCR mix (Applied Biosystems) in an
Applied Biosystems 7300 Real-Time PCR system) to compare
quantitive DNA differences between Ome/+ and +/+ mice. Then
wesequencedcDNAonlytoshowthatexon1wassplicedtoexon4.
Because the precise location of the mutation is unknown, RT-
PCR was used to genotype the mice. Primers anchored in exons 1
and 4 yield a 150-bp band for cDNA made from the heterozygous
mice. These primers do not amplify a detectable product from wild-
typecDNAunderstandardPCRconditionsbecauseoftheproduct’s
large size (,2 kb). Briefly, total RNA was prepared from the whole
ear using the PureLink
TM Micro-to-Midi
TM Total RNA Purifica-
tion System (Invitrogen). From each sample, 2 mg of total RNA
template were used to synthesize cDNA using a SuperScript First-
Strand Synthesis System. 1 ml of cDNA from each sample was
subjected to PCR amplification in a Bio-Rad PTC-200 Peltier
thermal cycler. Heterozygous mice were genotyped by detecting a
truncated allele using a forward primer (1F, 59-ctgactagcccgagc-
gaaggag-39)andareverseprimer(4R,59-tggacacctgggtcttcgtc-39)to
Figure 6. Skull and Eustachian tube measurement of Chd7 mutant mice and littermate control mice. (A, B) Schematic diagrams
superimposed on dissected skulls indicate the measured Eustachian tube angles (A) and skull dimensions (B). (C, D) Quantitative evaluation of the
Eustachian tube angles and the skull dimensions in mutant and littermate control mice. Mutant mice have larger Eustachian tube angles of both ears
than do the littermate control mice. Skull measurements indicated a greater skull height/skull length and nose bone length/skull length ratio in the
mutant mice compared to littermate control mice.
doi:10.1371/journal.pone.0034944.g006
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cagactcccatcctcgccaaaaa-39)anchoredinexon2wasusedaspositive
control forthe wild-typeallele. Amplificationconditionswere94uC
for2 min;followedby28cyclesof94uCfor30 s,60uCfor40 sand
72 uC for 50 s; followed by 5 min at 72 uC. Ten ml of the PCR
products were subject to 2% agarose gel electrophoresis.
Comprehensive evaluation of hearing loss in Chd7
mutant mice
Hearingwasevaluatedinanesthetized (Avertin,0.5 mg/gmouse
mass) wild-type and Chd7
Ome/+ mice by using auditory brainstem
response (ABR, measures auditory nerve and brainstem pathways
involved in hearing), distortion product otoacoustic emissions
(DPOAE,measuresouterhair-cellfunctionandpredictsconductive
hearing loss [42]), and tympanometry (measures tympanic mem-
brane and ossicle chain function). A computer-aided evoked
potential system (Intelligent Hearing Systems) was used to measure
mouse ABR thresholds and DPOAE amplitudes as previously
described [42,43]. An Race Car tympanometer from Maico
Diagnostics (Eden Prairie, MN, USA) was used to examine the
tympaniogram following the procedures described previously [44].
Figure 7. Immunohistochemical staining of Chd7 protein in the developing middle ear. CHD7, revealed by green fluorescence, is
expressed in the middle ear epithelium (A, C) and in the organ of Corti (A, E) in the inner ear of a wild-type mouse. MEC, middle ear cavity; IHC, inner
hair cell; OHC, outer hair cell. Scale bars: A=50 mm.
doi:10.1371/journal.pone.0034944.g007
Figure 8. RT–PCR analysis of middle ears in Chd7
Ome/+ mice.
Total RNA isolated from three Chd7
Ome/+ (mutant) and three wild-type
littermate mice (control) were used to generate cDNA by reverse
transcription. The cDNA was amplified using primers specific for Gapdh,
Muc5a, Muc5b and Tgf- b1. The mutant mice showed significantly
elevated expression levels for all three genes assayed, relative to Gapdh
expression. Graph represents the digitized quantification of bands from
an agarose gel. Error bars represent standard deviation from the mean,
for each sample.
doi:10.1371/journal.pone.0034944.g008
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Histological analyses of the middle and inner ears were
performed following the methods described previously [45].
Briefly, middle and inner ears from Chd7
Ome/+ mice and wild-
type mice were dissected after transcardial perfusion with 4%
paraformaldehyde (PFA). Ear samples were immersed in 4% PFA
for 48 h at 4uC, decalcified with 10% EDTA solution and
embedded in paraffin. Sections (7 mm) were cut using an American
Optical model 820 rotary microtome (American Optical, Buffalo,
New York, USA), mounted onto Fisher Superfrost Plus slides
(Fisher Scientific, Pittsburgh, PA) and counterstained in hematox-
ylin/eosin (H&E). Cryosections were prepared similarly but
without dehydration, and instead, rinsed in a series of sucrose
solutions and then embedded in Tissue-Tek OCT (Sakyra Finetek,
Torrence, CA). Sections (10 mm) were cut with a Leica CM1900
cryostat microtome (Leica, Nussloch, Germany). Goblet cells,
whose sole function is to secrete mucus, were identified by Mayer’s
Mucicarmine staining method following the protocol provided by
Electron Microscopy Sciences (Catalog #26320).
Scoring system for pathology of middle ears
A scoring system of -/+/++/+++ was used to assess the severity
of pathology in the middle and inner ears following a previously
described method [25,45]. Histological analysis of the middle ears
of control and mutant mice was performed using a light
microscope (Leica DFC500, Germany). For the absence of
pathology, a ‘–’ symbol was assigned. When pathology was very
scarce in the middle or inner ear, a ‘+’ symbol was assigned. If
pathology was more prevalent, but not to the point of spanning the
entire middle or inner ear, then ‘++’ was assigned. If pathology
spanned the entire middle or inner ear, then ‘+++’ was assigned.
The pathologies being scored included middle ear effusion,
inflammatory cell infiltration, tissue debris, and tissue prolifera-
tion. Both ears were examined in each mouse and only the one
with more severe alteration was evaluated. Numerical scores were
assigned to allow for semi-quantitative analysis of pathology
(scoring 1 point for each +; for a total maximum possible score of
12 per mouse). A chi-square test was used to statistically evaluate
the semi-quantitative data.
Scanning electron microscopy (SEM)
Middle and inner ears from Chd7
Ome/+ and wild-type mice were
dissected after transcardial perfusion with 4% paraformaldehyde
(PFA) and then immersed in 2.5% glutaraldehyde in 0.1 M
phosphate buffered saline (PBS, pH=7.2) for 4 hours at 4uC.
Dissection was performed to expose the middle ear cavities and
inner ear basilar membrane. After post-fixation in 1% OsO4 in
0.1 M PBS (pH=7.2, 1 hour), samples were washed in 0.1 M PBS
(pH=7.2), dehydrated in increasing concentrations of ethanol,
dried in a BAL-TEC CPD 030 critical point dryer (BAL-TEC
GmbH, Witten, Germany) according to manufacturer’s instruc-
tions and analyzed in a Hitachi S-4500 scanning electron
microscope (Hitachi, Tokyo, Japan) at 5 kV.
Bacterial culture and identification
Bacterial culture and identification were performed following
the protocol described previously [45]. Briefly, the bullae were
removed and the middle ears were isolated under sterile conditions
after ABR thresholds were determined. After microscopic
examination, middle ears were washed with sterile PBS. 100 ml
of the PBS lavage were inoculated onto a BBLTM Trypticase
TM
Soy Agar plate with 5% sheep blood (TSA II, Fisher, Pittsburgh,
PA, USA) and the plates were incubated at 37uC with 5% CO2 for
18 h. Bacterial colonies were sorted by colony appearance,
counted and subjected to further identification.
Immunohistochemistry
Cryosections were fixed in 1.5% PFA for 10 min. After being
washed twice in 1x PBS and blocked in 5% bovine serum albumin
for 1 h at room temperature, the samples were immersed in rabbit
anti-Chd7 polyclonal antibody (1:200 dilution, Abcam, Inc.,
ab31824, Cambridge, MA) and incubated at 4uC overnight. The
samples were washed twice in 1x PBS for 5 min each, immersed in
goat anti-rabbit secondary antibody conjugated to Alexa Fluor 488
(1:500 dilution; Invitrogen) and incubated at room temperature for
1 h. After counterstaining with PI for 15 min, the samples were
mounted with Vectashield mounting medium (H-1000, Vector
Laboratories). The samples were observed under an immunofluo-
rescence microscope (Leica) and analyzed with Photoshop CS4
software.
Preparation of the skull and craniofacial measurement
To measure craniofacial dimensions in control and mutant
mice, the skulls were dissected and removed from 5 mutant mice
and 8 control mice at age 3 months. Skulls were macerated in 1%
potassium hydroxide overnight to remove any soft tissue and then
stained with alizarin red, as previously described [46]. After
staining, the skulls were stored in undiluted glycerin until
measurements were taken. To measure the dimensions of interest,
a hand-held digital caliper (General Tools & Instruments, NY)
with a resolution of 0.01 mm was used. These instruments provide
a precise and accurate mode of measurement for small distances,
necessary here because great precision and accuracy is needed to
distinguish differences between control and mutant mice.
Measurements were recorded in millimeters and results for control
and mutant mice were graphed; this method has been previously
validated for accuracy and precision [47,48]. Forty-four landmarks
were adapted mostly from Dr. Joan Richtsmeier’s paper on
craniofacial dysmorphology in a Down syndrome mouse model
[48], and from the standard measurement protocol in the Jackson
Laboratory Craniofacial mutant source (Jackson Laboratory, Bar
Harbor, ME http://craniofacial.jax.org/standard_protocols.
html). Another measurement recorded was the angle between
Table 3. Sequences of primers used for RNA analysis.
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tube for both control and mutant mice. The skulls were then
examined under an anatomical microscope and the skull base was
photographed. The screen ruler software MB-Ruler 4.0 (Markus
Bader, http://www.markus-bader.de/MB-Ruler/download.htm)
was used to precisely locate the lines to be used for angle
measurement and to measure the angles. The measurement data
was statistically analyzed using the Student t test.
RNA analysis
The same cDNA template and PCR conditions from the
previous genotyping step were used to profile mRNA accumula-
tion of Muc5ac, Muc5b and Tgf-b1 in the Chd7 mice by methods
previously described [49]. PCR products were subjected to
electrophoresis and the gray intensity of each band on a 2%
agarose gel was digitized using ImageJ software (NIH) and
corrected by the coefficient of Gapdh (glyceraldehyde-3-phosphate
dehydrogenase) gene expression level of the same sample. Primers
used for RNA analysis are listed in Table 3.
Statistics
The Student t test was used for comparing mean ABR
thresholds. Semi-quantitative data assessing ear pathology were
analyzed by a chi-square test. A value of P,0.05 was considered
significant.
Supporting Information
Video S1 A Chd7
Ome/+ mouse showing circling behavior in
Video S1.
(MP4)
Video S2 A Chd7Ome/+ mouse showing poor swimming ability
(Video S2).
(MP4)
Video S3 A Chd7+/+ mouse showing normal swimming ability
with his nose above water (Video S3).
(MP4)
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